Sound Shore Fund N-PX Annual report of proxy voting record

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM N-PX

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT

INVESTMENT COMPANY

Investment Company Act file number 811-04244

Sound Shore Fund, Inc.

Three Canal Plaza, Suite 600

Portland, ME 04101
(Address of Principal Executive Offices)

T. Gibbs Kane, Jr., President

8 Sound Shore Drive

Greenwich, Connecticut 06830

(Name and address of agent for service)

Registrant’s telephone number, including area code: 800-551-1980

Date of fiscal year end: December 31

Date of reporting period: July 1, 2022 - June 30, 2023

ITEM 1. PROXY VOTING RECORD

Sound Shore Fund Proxy Voting from July 1, 2022 through June 30, 2023
										Voted
			Meeting	# of		Type of	Proposed	Date	How	with / against
Security	Ticker	CUSIP	Date	Shares	Proposal Description	Proposal	by	Voted	Voted	Management
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1a. Re-Election of Director:  Revathi Advaithi	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1b. Re-Election of Director:  Michael D. Capellas	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1c. Re-Election of Director:  John D. Harris II	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1d. Re-Election of Director:  Michael E. Hurlston	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1e. Re-Election of Director:  Erin L. McSweeney	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1f. Re-Election of Director:  Marc A. Onetto	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1g. Re-Election of Director:  Charles K. Stevens, III	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1h. Re-Election of Director:  Lay Koon Tan	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1i. Re-Election of Director:  Patrick J. Ward	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	1j. Re-Election of Director:  William D. Watkins	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	2. To Approve the Re-Appointment of Deloitte & Touche LLP as Independent Auditors for the 2023 Fiscal Year and to Authorize the Board of Directors,Upon the Recommendation of the Audit Committee, to Fix their Remuneration	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	3.  NON-BINDING, ADVISORY RESOLUTION.  To Approve the Compensation of the Company's Named Executive Officers	Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	4.  To Approve a General Authorization for the Directors of Flex to Allot and Issue Ordinary Shares	Non-Routine	Management	08/10/22	FOR	WITH
Flex Ltd.	FLEX	Y2573F102	08/25/22	2,586,795	5.  To Approve a Renewal of the Share Purchase Mandate Permitting Flex to Purchase or otherwise Acquire Its Own Issued Ordinary Shares	Non-Routine	Management	08/10/22	FOR	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	1.  Election of Directors - 15 Nominees	Routine	Management	09/13/22	FOR	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	2.  Advisory Vote to Approve Named Executive Officer Compensation	Routine	Management	09/13/22	FOR	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	3.  Ratify the Appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm	Routine	Management	09/13/22	FOR	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	4.  Approval to the Amendment to the FedEx Corporation 2019 Omnibus Stock Incentive Plan to Increase the Number of Authorized Shares	Non-Routine	Management	09/13/22	FOR	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	5.  Proposal Regarding Independent Board Chairman	Non-Routine	Shareholder	09/13/22	FOR	AGAINST
FedEx Corporation	FDX	31428X106	09/19/22	107,655	6.  Proposal Regarding Report on Alignment between Company Values and Electioneering Contributions	Non-Routine	Shareholder	09/13/22	AGAINST	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	7.  Proposal Regarding Lobbying Activity and Expenditure Report	Non-Routine	Shareholder	09/13/22	AGAINST	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	8.  Proposal Regarding Assessing Inclusion in the Workplace	Non-Routine	Shareholder	09/13/22	AGAINST	WITH
FedEx Corporation	FDX	31428X106	09/19/22	107,655	9.  Proposal Regarding Report on Climate Lobbying	Non-Routine	Shareholder	09/13/22	FOR	AGAINST
Conagra Brands, Inc.	CAG	205887102	09/21/22	742,375	1.  Election of Directors - 10 Nominees	Routine	Management	09/13/22	FOR	WITH
Conagra Brands, Inc.	CAG	205887102	09/21/22	742,375	2.  Ratification of the Appointment of KPMG LLP as the Independent Auditor	Routine	Management	09/13/22	FOR	WITH
Conagra Brands, Inc.	CAG	205887102	09/21/22	742,375	3.  Advisory Approval of Named Executive Officer Compensation	Routine	Management	09/13/22	FOR	WITH
Conagra Brands, Inc.	CAG	205887102	09/21/22	742,375	4.  A Board Resolution to Amend the Certificate of Incorporation to Allow Shareholders to Act by Written Consent	Non-Routine	Management	09/13/22	FOR	WITH
Conagra Brands, Inc.	CAG	205887102	09/21/22	742,375	5.  Proposal Regarding the Office of the Chair and the Office of the Chief Executive Officer	Non-Routine	Shareholder	09/13/22	AGAINST	WITH
Cardinal Health, Inc.	CAH	14149Y108	11/09/22	355,900	1.  Election of Directors - 13 Nominees	Routine	Management	10/31/22	FOR	WITH
Cardinal Health, Inc.	CAH	14149Y108	11/09/22	355,900	2.  Ratify the Appointment of Ernst & Young LLP as Independent Auditor	Routine	Management	10/31/22	FOR	WITH
Cardinal Health, Inc.	CAH	14149Y108	11/09/22	355,900	3.  Approve, on a Non-Binding Advisory Basis, the Compensation of Named Executive Officers	Routine	Management	10/31/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.1  Elect Director - Awo Ablo	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.2  Elect Director - Jeffrey S. Berg	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.3  Elect Director - Michael J. Boskin	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.4  Elect Director - Safra A. Catz	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.5  Elect Director - Bruce R. Chizen	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.6  Elect Director - George H. Conrades	Routine	Management	11/11/22	WITHHOLD	AGAINST
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.7  Elect Director - Lawrence J. Ellison	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.8  Elect Director - Rona A. Fairhead	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.9  Elect Director - Jeffrey O. Henley	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.10  Elect Director - Renee J. James	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.11  Elect Director - Charles W. Moorman	Routine	Management	11/11/22	WITHHOLD	AGAINST
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.12  Elect Director - Leon E. Panetta	Routine	Management	11/11/22	WITHHOLD	AGAINST
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.13  Elect Director - William G. Parrett	Routine	Management	11/11/22	WITHHOLD	AGAINST
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.14  Elect Director - Naomi O. Seligman	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	1.15  Elect Director - Vishal Sikka	Routine	Management	11/11/22	FOR	WITH
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	2.  Advisory Vote to Approve the Compensation of Named Executive Officers	Routine	Management	11/11/22	AGAINST	AGAINST
Oracle Corporation	ORCL	68389X105	11/16/22	481,405	3.  Ratify the Selection of Ernst & Young LLP as Independent Registered Public Accounting Firm	Routine	Management	11/11/22	FOR	WITH
Micron Technology, Inc.	MU	595112103	01/12/23	351,105	1.  Election of Directors - 8 Nominees	Routine	Management	01/06/23	FOR	WITH
Micron Technology, Inc.	MU	595112103	01/12/23	351,105	2.  To Approve a Non-Binding Resolution to Approve the Compensation of Named Executive Officers	Routine	Management	01/06/23	FOR	WITH
Micron Technology, Inc.	MU	595112103	01/12/23	351,105	3.  To Approve the Amended and Restated 2007 Equity Incentive Plan to Increase the Shares Reserved for Issuance Therunder by 50 Million	Non-Routine	Management	01/06/23	FOR	WITH
Micron Technology, Inc.	MU	595112103	01/12/23	351,105	4.  Ratify the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm	Routine	Management	01/06/23	FOR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	1.  Election of Directors - 9 Nominees	Routine	Management	02/23/23	FOR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	2.  A Non-Binding Advisory Resolution to Approve Executive Compensation	Routine	Management	02/23/23	FOR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	3.  A Non-Binding Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation	Routine	Management	02/23/23	1 YEAR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	4.  Approval of the Hologic, Inc. Amended and Restated 2008 Equity Incentive Plan	Non-Routine	Management	02/23/23	FOR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	5.  Approval of the Hologic, Inc. Amended and Restated 2012 Employee Stock Purchase Plan	Non-Routine	Management	02/23/23	FOR	WITH
Hologic, Inc.	HOLX	436440101	03/09/23	298,785	6.  Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	02/23/23	FOR	WITH
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	1.  Election of Directors - 10 Nominees	Routine	Management	02/23/23	FOR	WITH
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	2.  Approval, on an Advisory Basis, of the Compensation of Applied Materials' Named Executive Officers	Routine	Management	02/23/23	FOR	WITH
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	3.  Approval, on an Advisory Basis, the Frequency of Holding an Advisory Vote on Executive Compensation	Routine	Management	02/23/23	1 YEAR	WITH
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	4.  Ratification of KPMG LLP as Applied Materials' Independent Registered Public Accounting Firm	Routine	Management	02/23/23	FOR	WITH
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	5.  Proposal to Amend the Appropriate Governing Documents to Give the Owners of a Combined 10% of the Companies Outstanding Common Stock the Power to Call a Special Shareholder Meeting	Non-Routine	Shareholder	02/23/23	FOR	AGAINST
Applied Materials, Inc.	AMAT	038222105	03/09/23	195,570	6.  Proposal to Improve the Executive Compensation Program and Policy to Include the CEO Pay Ratio Factor	Non-Routine	Shareholder	02/23/23	AGAINST	WITH
Lennar Corporation	LEN	526057104	04/12/23	323,995	1.  Election of Directors - 10 Nominees	Routine	Management	03/23/23	FOR	WITH
Lennar Corporation	LEN	526057104	04/12/23	323,995	2.  Approval, on an Advisory Basis, of the Compensation of Lennar Corporation Named Executive Officers	Routine	Management	03/23/23	FOR	WITH
Lennar Corporation	LEN	526057104	04/12/23	323,995	3.  Approval, on an Advisory Basis, the Frequency of the Stockholder Vote on Compensation of Named Executive Officers	Routine	Management	03/23/23	1 YEAR	WITH
Lennar Corporation	LEN	526057104	04/12/23	323,995	4.  Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	03/23/23	FOR	WITH
Lennar Corporation	LEN	526057104	04/12/23	323,995	5.  Proposal Regarding the Elimination of the Company's Dual-Class Common Stock Voting Structure	Non-Routine	Shareholder	03/23/23	FOR	AGAINST
Boeing Company	BA	097023105	04/18/23	95,330	1.  Election of Directors - 13 Nominees	Routine	Management	03/31/23	FOR	WITH
Boeing Company	BA	097023105	04/18/23	95,330	2.  Approve, on an Advisory Basis, Named Executive Officer Compensation	Routine	Management	03/31/23	AGAINST	AGAINST
Boeing Company	BA	097023105	04/18/23	95,330	3.  Approve, on an Advisory Basis, the Frequency of Future Advisory Votes on Named Executive Officer Compensation	Routine	Management	03/31/23	1 YEAR	WITH
Boeing Company	BA	097023105	04/18/23	95,330	4.  Approve the Boeing Company 2023 Incentive Stock Plan	Non-Routine	Management	03/31/23	FOR	WITH
Boeing Company	BA	097023105	04/18/23	95,330	5.  Ratify the Appointment of Deloitte & Touche LLP as Independent Auditor	Routine	Management	03/31/23	FOR	WITH
Boeing Company	BA	097023105	04/18/23	95,330	6.  Proposal Regarding China Report	Non-Routine	Shareholder	03/31/23	AGAINST	WITH
Boeing Company	BA	097023105	04/18/23	95,330	7.  Proposal Regarding Report on Lobbying Activities	Non-Routine	Shareholder	03/31/23	AGAINST	WITH
Boeing Company	BA	097023105	04/18/23	95,330	8.  Proposal Regarding Report on Climate Lobbying	Non-Routine	Shareholder	03/31/23	AGAINST	WITH
Boeing Company	BA	097023105	04/18/23	95,330	9.  Proposal Regarding Pay Equity Disclosure	Non-Routine	Shareholder	03/31/23	AGAINST	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	1.  Election of Directors - 14 Nominees	Routine	Management	04/14/23	FOR	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	2.  Approving the Executive Compensation (an Advisory, Non-Binding "Say on Pay" Resolution)	Routine	Management	04/14/23	AGAINST	AGAINST
Bank of America Corporation	BAC	060505104	04/25/23	658,445	3.  A Vote on the Frequency of Future "Say on Pay" Resolutions (an Advisory, Non-Binding "Say on Frequency" Resolution)	Routine	Management	04/14/23	1 YEAR	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	4.  Ratify the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm	Routine	Management	04/14/23	FOR	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	5.  Amending and Restating the Bank of America Corporation Equity Plan	Non-Routine	Management	04/14/23	FOR	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	6.  Proposal Requesting an Independent Board Chair	Non-Routine	Shareholder	04/14/23	FOR	AGAINST
Bank of America Corporation	BAC	060505104	04/25/23	658,445	7.  Proposal Requesting Shareholder Ratification of Termination Pay	Non-Routine	Shareholder	04/14/23	AGAINST	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	8.  Proposal Requesting Greenhouse Gas Reduction Targets	Non-Routine	Shareholder	04/14/23	AGAINST	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	9.  Proposal Requesting Report on Transition Planning	Non-Routine	Shareholder	04/14/23	FOR	AGAINST
Bank of America Corporation	BAC	060505104	04/25/23	658,445	10.  Proposal Requesting Adoption of Policy to Cease Financing New Fossil Fuel Supplies	Non-Routine	Shareholder	04/14/23	AGAINST	WITH
Bank of America Corporation	BAC	060505104	04/25/23	658,445	11.  Proposal Requesting a Racial Equity Audit	Non-Routine	Shareholder	04/14/23	AGAINST	WITH
Constellation Energy Corporation	CEG	21037T109	04/25/23	236,515	1.  Election of Directors - 3 Nominees	Routine	Management	04/06/23	FOR	WITH
Constellation Energy Corporation	CEG	21037T109	04/25/23	236,515	2.  To Consider and Act on an Advisory Vote Regarding the Approval of Compensation Paid to Named Executive Officers	Routine	Management	04/06/23	FOR	WITH
Constellation Energy Corporation	CEG	21037T109	04/25/23	236,515	3.  To Consider and Act on an Advisory Vote Regarding the Frequency of the  Approval of Compensation Paid to Named Executive Officers	Routine	Management	04/06/23	1 YEAR	WITH
Constellation Energy Corporation	CEG	21037T109	04/25/23	236,515	4.  Ratify the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm	Routine	Management	04/06/23	FOR	WITH
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	1.  Election of Directors - 12 Nominees	Routine	Management	04/05/23	FOR	WITH
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	2.  Advisory Resolution to Approve Executive Compensation	Routine	Management	04/05/23	FOR	WITH
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	3.  Advisory Vote on the Frequency of Executive Compensation Votes	Routine	Management	04/05/23	1 YEAR	AGAINST
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	4.  Advisory Vote on the Ratification of Ernst & Young LLP as Independent Auditors	Routine	Management	04/05/23	FOR	WITH
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	5.  Proposal Regarding Ratification of Executive Termination Pay	Non-Routine	Shareholder	04/05/23	AGAINST	WITH
Paccar, Inc.	PCAR	693718108	04/25/23	300,172	6.  Proposal Regarding a Report on Climate-Related Policy Engagement	Non-Routine	Shareholder	04/05/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	1.  Election of Directors - 13 Nominees	Routine	Management	04/13/23	FOR	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	2.  Advisory Resolution to Approve Executive Compensation (Say on Pay)	Routine	Management	04/13/23	FOR	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	3.  Advisory Resolution on the Frequency of Future Advisory Votes to Approve Executive Compensation (Say on Frequency)	Routine	Management	04/13/23	1 YEAR	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	4.  Ratify the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/13/23	FOR	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	5.  Proposal - Adopt Simple Majority Vote	Non-Routine	Shareholder	04/13/23	FOR	AGAINST
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	6.  Proposal - Report on Congruency of Political Spending	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	7.  Proposal - Climate Lobbying Report	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	8.  Proposal - Climate Transition Report	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	9.  Proposal - Fossil Fuel Lending Policy	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	10. Proposal - Annual Report on Prevention of Workplace Harassment and Discrimination	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Wells Fargo & Company	WFC	949746101	04/25/23	846,570	11. Proposal - Policy on Freedom of Association and Collective Bargaining	Non-Routine	Shareholder	04/13/23	AGAINST	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	1.  Election of Directors - 12 Nominees	Routine	Management	04/20/23	FOR	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	2.  Ratify the Selection of KPMG LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/20/23	FOR	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	3.  2023 Advisory Approval of Executive Compensation	Routine	Management	04/20/23	FOR	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	4.  Advisory Vote on Frequency of Future Advisory Votes to Approve Executive Compensation	Routine	Management	04/20/23	1 YEAR	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	5.  Proposal Regarding Ratification of Termination Pay	Non-Routine	Shareholder	04/20/23	AGAINST	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	6.  Proposal Regarding Independent Board Chairman Policy	Non-Routine	Shareholder	04/20/23	FOR	AGAINST
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	7.  Proposal Regarding Transfer of Intellectual Property to Potential COVID-19 Manufacturers Feasibility Report	Non-Routine	Shareholder	04/20/23	AGAINST	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	8.  Proposal Regarding Impact of Extended Patent Exclusivities on Product Access Report	Non-Routine	Shareholder	04/20/23	AGAINST	WITH
Pfizer, Inc.	PFE	717081103	04/27/23	799,530	9.  Proposal Regarding Political Contributions Congruency Report	Non-Routine	Shareholder	04/20/23	AGAINST	WITH
Huntington Ingalls Industries, Inc.	HII	446413106	05/02/23	111,445	1.  Election of Directors - 11 Nominees	Routine	Management	04/20/23	FOR	WITH
Huntington Ingalls Industries, Inc.	HII	446413106	05/02/23	111,445	2.  Approve Executive Compensation on an Advisory Basis	Routine	Management	04/20/23	FOR	WITH
Huntington Ingalls Industries, Inc.	HII	446413106	05/02/23	111,445	3.  Ratify the Appointment of Deloitte & Touche LLP as Independent Auditors	Routine	Management	04/20/23	FOR	WITH
Huntington Ingalls Industries, Inc.	HII	446413106	05/02/23	111,445	4.  Proposal Requesting that the Company Disclose on Its Website the Annual Report of the Its Direct and Indirect Lobbying Activities and Expenditures	Non-Routine	Shareholder	04/20/23	AGAINST	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	1.  Election of Directors - 15 Nominees	Routine	Management	04/28/23	FOR	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	2.  Non-Binding Resolution to Approve the Compensation of the Company's Named Executive Officers	Routine	Management	04/28/23	AGAINST	AGAINST
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	3.  Non-Binding Resolution to Determine the Frequency (whether Annual, Biennial or Triennial) with which Shareholders of the Company shall be Entitled to have an Advisory Vote on Executive Compensation	Routine	Management	04/28/23	1 YEAR	AGAINST
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	4.  Proposal Regarding how the Company Manages Physical and Transitional Climate Related Risks and Opportunities	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	5.  Proposal Regarding how Climate Related Risks are being Governed by the Company	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	6.  Proposal Regarding how the Company Intends to Measure, Disclose and Reduce GHG Emissions Associated with Its Underwriting, Insuring and Investment Activities	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	7.  Proposal Regarding the Reporting on the Effectiveness of the Corporation's Diversity, Equity and Inclusion Efforts	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	8.  Proposal Regarding the Adoption of a Policy Requiring that Two Separate People Hold the Offices of the Chairman and the CEO	Non-Routine	Shareholder	04/28/23	FOR	AGAINST
Berkshire Hathaway, Inc. Cl B	BRK/B	084670702	05/06/23	97,575	9.  Proposal Requesting that the Company Avoid Supporting or Taking a Public Policy Position on Controversial Social and Political Issues	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	1.  Election of Directors - 12 Nominees	Routine	Management	04/28/23	FOR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	2.  Approval of Amendments to the Company's Restated Certificate of Incorporation to Remove Remaining Supermajority Voting Requirements and References to Signet Banking Corporation	Non-Routine	Management	04/28/23	FOR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	3.  Advisory Vote on the Frequency of Holding an Advisory Vote to Approve the Company's Named Executive Officer Compensation ("Say When on Pay")	Routine	Management	04/28/23	1 YEAR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	4.  Advisory Vote on the Company's Named Executive Officer Compensation ("Say on Pay")	Routine	Management	04/28/23	FOR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	5.  Approval and Adoption of the Company's Seventh Amended and Restated 2004 Stock Incentive Plan	Non-Routine	Management	04/28/23	FOR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	6.  Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/28/23	FOR	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	7.  Proposal Requesting a Simple Majority Vote	Non-Routine	Shareholder	04/28/23	FOR	AGAINST
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	8.  Proposal Requesting a Report on Board Oversight of Risks Related to Discrimination	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Capital One Financial Corporation	COF	14040H105	05/04/23	250,295	9.  Proposal Requesting a Board Skills and Diversity Matrix	Non-Routine	Shareholder	04/28/23	AGAINST	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	1.  Election of Directors - 10 Nominees	Routine	Management	05/02/23	FOR	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	2.  Advisory Vote to Approve Executive Compensation	Routine	Management	05/02/23	FOR	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	3.  Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation	Routine	Management	05/02/23	1 YEAR	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	4.  Ratification of the Appointment of KPMG LLP as the Company's Independent Public Accounting Firm	Routine	Management	05/02/23	FOR	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	5.  Proposal for Shareholder Ratification of Termination Pay	Non-Routine	Shareholder	05/02/23	AGAINST	WITH
Centene Corporation	CNC	15135B101	05/10/23	278,305	6.  Proposal for Maternal Morbidity Reduction Metrics in Executive Compensation	Non-Routine	Shareholder	05/02/23	AGAINST	WITH
Kinder Morgan, Inc.	KMI	49456B101	05/10/23	1,289,075	1.  Election of Directors - 14 Nominees	Routine	Management	05/04/23	FOR	WITH
Kinder Morgan, Inc.	KMI	49456B101	05/10/23	1,289,075	2.  Approval of an Amendment to the Company's Amended and Restated Certificate of Incorporation to Limit the Liability of Certain Officers of the Company as Permitted by Recent Amendments to the General Corporation Law of the State of Delaware	Non-Routine	Management	05/04/23	FOR	WITH
Kinder Morgan, Inc.	KMI	49456B101	05/10/23	1,289,075	3.  Ratification of the Selection of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm	Routine	Management	05/04/23	FOR	WITH
Kinder Morgan, Inc.	KMI	49456B101	05/10/23	1,289,075	4.  Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers	Routine	Management	05/04/23	FOR	WITH
Avantor, Inc.	AVTR	05352A100	05/11/23	948,320	1.  Election of Directors - 10 Nominees	Routine	Management	04/28/23	FOR	WITH
Avantor, Inc.	AVTR	05352A100	05/11/23	948,320	2.  Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/28/23	FOR	WITH
Avantor, Inc.	AVTR	05352A100	05/11/23	948,320	3.  Approve, on an Advisory Basis, Named Executive Officer Compensation	Routine	Management	04/28/23	FOR	WITH
Vistra Corporation	VST	92840M102	05/02/23	1,688,430	1.  Election of Directors - 11 Nominees	Routine	Management	04/20/23	FOR	WITH
Vistra Corporation	VST	92840M102	05/02/23	1,688,430	2.  Approve, on an Advisory Basis,  the 2022 Compensation of the Company's Named Executive Officers	Routine	Management	04/20/23	FOR	WITH
Vistra Corporation	VST	92840M102	05/02/23	1,688,430	3.  Ratify the Selection of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/20/23	FOR	WITH
Cleveland-Cliffs, Inc.	CLF	185899101	05/17/23	1,187,415	1.  Election of Directors - 10 Nominees	Routine	Management	05/04/23	FOR	WITH
Cleveland-Cliffs, Inc.	CLF	185899101	05/17/23	1,187,415	2.  Approval, on an Advisory Basis, of the Company's Named Executive Officers' Compensation	Routine	Management	05/04/23	FOR	WITH
Cleveland-Cliffs, Inc.	CLF	185899101	05/17/23	1,187,415	3.  Approval, on an Advisory Basis, of the Frequency of Shareholder Votes on the Company's Named Executive Officers' Compensation	Routine	Management	05/04/23	1 YEAR	WITH
Cleveland-Cliffs, Inc.	CLF	185899101	05/17/23	1,187,415	4.  Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	05/04/23	FOR	WITH
Baker Hughes Company	BKR	05722G100	05/16/23	607,095	1.  Election of Directors - 9 Nominees	Routine	Management	04/28/23	FOR	WITH
Baker Hughes Company	BKR	05722G100	05/16/23	607,095	2.  An Advisory Vote Related to the Company's Executive Compensation Program	Routine	Management	04/28/23	FOR	WITH
Baker Hughes Company	BKR	05722G100	05/16/23	607,095	3.  The Ratification of KPMG LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	04/28/23	FOR	WITH
Baker Hughes Company	BKR	05722G100	05/16/23	607,095	4.  An Advisory Vote on the Frequency of the Holding of an Advisory Vote on Executive Compensation	Routine	Management	04/28/23	1 YEAR	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	1.  Election of Directors - 13 Nominees	Routine	Management	05/16/23	FOR	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	2.  Non-Binding Advisory Vote to Approve the Compensation of the Company's Named Executive Officers	Routine	Management	05/16/23	FOR	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	3.  Non-Binding Advisory Vote to Approve the Frequency of Future Votes to Approve Compensation of the Company's Named Executive Officers	Routine	Management	05/16/23	1 YEAR	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	4.  Ratification of the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm	Routine	Management	05/16/23	FOR	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	5.  Proposal Regarding Business Operations in China	Non-Routine	Shareholder	05/16/23	AGAINST	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	6.  Proposal Regarding Access to COVID-19 Products	Non-Routine	Shareholder	05/16/23	AGAINST	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	7.  Proposal Regarding Indirect Political Spending	Non-Routine	Shareholder	05/16/23	AGAINST	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	8.  Proposal Regarding Patents and Access	Non-Routine	Shareholder	05/16/23	AGAINST	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	9.  Proposal Regarding a Congruency Report of Partnerships with Globalist Organizations	Non-Routine	Shareholder	05/16/23	AGAINST	WITH
Merck & Co., Inc.	MRK	58933Y105	05/23/23	204,445	10. Proposal Regarding an Independent Board Chairman	Non-Routine	Shareholder	05/16/23	FOR	AGAINST
GE HealthCare Technologies Inc.	GEHC	36266G107	05/23/23	323,330	1.  Election of Directors - 10 Nominees	Routine	Management	05/16/23	FOR	WITH
GE HealthCare Technologies Inc.	GEHC	36266G107	05/23/23	323,330	2.  Approve the Company's Named Executive Officers' Compensation in an Advisory Vote	Routine	Management	05/16/23	FOR	WITH
GE HealthCare Technologies Inc.	GEHC	36266G107	05/23/23	323,330	3.  Approve the Frequency of Future Advisory Votes on Named Executive Officers' Compensation in an Advisory Vote	Routine	Management	05/16/23	1 YEAR	WITH
GE HealthCare Technologies Inc.	GEHC	36266G107	05/23/23	323,330	4.  Ratifiy the Appointment of Deloitte & Touche LLP as the Company's Independent Auditor	Routine	Management	05/16/23	FOR	WITH
Robert Half International, Inc.	RHI	770323103	05/17/23	235,360	1.  Election of Directors - 8 Nominees	Routine	Management	05/02/23	FOR	WITH
Robert Half International, Inc.	RHI	770323103	05/17/23	235,360	2.  Advisory Vote to Approve Executive Compensation	Routine	Management	05/02/23	FOR	WITH
Robert Half International, Inc.	RHI	770323103	05/17/23	235,360	3.  Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation	Routine	Management	05/02/23	1 YEAR	WITH
Robert Half International, Inc.	RHI	770323103	05/17/23	235,360	4.  Ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	05/02/23	FOR	WITH
Victoria's Secret & Co.	VSCO	926400102	05/25/23	649,830	1.  Election of Directors - 8 Nominees	Routine	Management	05/04/23	FOR	WITH
Victoria's Secret & Co.	VSCO	926400102	05/25/23	649,830	2.  To Approve, on an Advisory Basis, the Compensation of the Company's Named Executive Officers	Routine	Management	05/04/23	FOR	WITH
Victoria's Secret & Co.	VSCO	926400102	05/25/23	649,830	3.  To Ratify the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	05/04/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	1.  Approval of the Statutory Financial Statements for the Fiscal Year Ended December 31, 2022	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	2.  Approval of the Consolidated Financial Statements for the Fiscal Year Ended December 31, 2022	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	3.  Allocation of Earnings and Declaration of Dividend for the Fiscal Year Ended December 31, 2022	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	4.  Authorization Granted to the Board of Directors, for a Period of Eighteen Months, to Trade in the Corporation Shares	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	5.  Agreements Covered by Articles L. 225-38 et seq. of the French Commercial Code	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	6.  Renewal of Ms. Marie-Christine Coisne-Roquette's Term as Director	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	7.  Renewal of Mr. Mark Cutifani's Term as Director	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	8.  Appointment of Mr. Dierk Paskert as Director	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	9.  Appointment of Ms. Anelise Lara as Director	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	10 Approval of the Information Relating to the Compensation of Executive and Non-Executive Directors ("Mandataires Sociaux") Mentioned in Paragraph I of Article L. 22-10-9 of the French Commercial Code	Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	11 Setting of the Amount of Directors' Aggregate Annual Compensation and Approval of the Compensation Policy	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	12 Approval of the Fixed, Variable and Extraordinary Components Making Up the Total Compensation and the In-Kind Benefits Paid During the Fiscal Year 2022 or Allocated for that Year to Mr. Patrick Pouyanné, Chairman and Chief Executive Officer	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	13 Approval of the Compensation Policy Applicable to the Chairman and Chief Executive Officer	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	14 Opinion on the Sustainability & Climate - Progress Report 2023, Reporting on the Progress made in the Implementation of the Corporation's Ambition with Respect to Sustainable Development and Energy Transition Towards Carbon Neutrality and Its Related Targets by 2030 and Complementing this Ambition	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	E15 Delegation of Authority to the Board of Directors, for a Period of Thirty-Eight Months, to Grant Corporation Free Shares, Existing or to be Issued, for the Benefit of the Company Employees and Executive Directors, or Some of Them, which Imply the Waiver by Shareholders of Their Pre-Emptive Subscription Right for Shares to be Issued	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	E16 Delegation of Competence Granted to the Board of Directors, for a Period of Twenty-Six Months, to Proceed to Capital Increases, with Cancellation of the Shareholders' Preemptive Subscription Right, Reserved to Members of a Company or Group Savings Plan	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	E17 Elimination of Double Voting Rights - Amendment to Article18 of the Corporation's Articles of Association - Powers to Carryout Formalities	Non-Routine	Management	05/18/23	FOR	WITH
TotalEnergies SE ADR	TTE	89151E109	05/26/23	406,930	A Shareholder Resolution on Targets for Indirect Scope 3 Emissions (Advisory Vote)	Non-Routine	Shareholder	05/18/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	1.  Adoption of the 2022 Statutory Annual Accounts	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	2. Discharge the Members of the Company's Board of Directors (the "Board") for Their Responsibilities in the Financial Year Ended December 31, 2022	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3a. Re-appoint Kurt Sievers as Executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3b. Re-appoint Annette Clayton as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3c. Re-appoint Anthony Foxx as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3d. Re-appoint Chunyuan Gu as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3e. Re-appoint Lena Olving as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3f.  Re-appoint Julie Southern as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3g.  Re-appoint Jasmin Staiblin as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3h.  Re-appoint Gregory Summe as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3i.  Re-appoint Karl-Henrik Sundström as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	3j.  Appoint Moshe Gavrielov as Non-executive Director	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	4.  Authorization of the Board to Issue Ordinary Shares of the Company ("Ordinary Shares") and Grant Rights to Acquire Ordinary Shares	Non-Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	5.  Authorization of the Board to Restrict or Exclude Preemption Rights Accruing in Connection with an Issue of Shares or Grant of Rights	Non-Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	6.  Authorization of the Board to Repurchase Ordinary Shares	Non-Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	7.  Authorization of the Board to Cancel Ordinary Shares Held or to be Acquired by the Company	Non-Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	8.  Re-appointment of Ernst & Young Accountants LLP as Independent Auditors	Routine	Management	05/10/23	FOR	WITH
NXPI Semiconductors N.V.	NXPI	N6596X109	05/24/23	176,730	9.  Non-binding, Advisory Vote to Approve Named Executive Officer Compensation	Routine	Management	05/10/23	FOR	WITH
Organon & Co.	OGN	68622V106	06/06/23	1,069,640	1.  Election of Class II Directors - 4 Nominees	Routine	Management	05/30/23	FOR	WITH
Organon & Co.	OGN	68622V106	06/06/23	1,069,640	2.  Approve, on a Non-Binding Advisory Basis, the Compensation of the Company's Named Executive Officers	Routine	Management	05/30/23	FOR	WITH
Organon & Co.	OGN	68622V106	06/06/23	1,069,640	3.  Ratify the Appointment of PricewaterhouseCoopers LLP as Company's Independent Registered Public Accounting Firm	Routine	Management	05/30/23	FOR	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	1.  Election of Directors - 13 Nominees	Routine	Management	06/15/23	FOR	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	2.  Ratification of the Selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm	Routine	Management	06/15/23	FOR	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	3.  Advisory Approval of Named Executive Officer Compensation	Routine	Management	06/15/23	FOR	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	4.  Approval of Amendment No. 1 to the Company's 2020 Long-Term Incentive Plan	Non-Routine	Management	06/15/23	FOR	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	5.  Proposal Requesting a Report on the Company's Operation in China	Non-Routine	Shareholder	06/15/23	AGAINST	WITH
General Motors Company	GM	37045V100	06/20/23	676,420	6.  Proposal Regarding Shareholder Written Consent	Non-Routine	Shareholder	06/15/23	FOR	AGAINST
General Motors Company	GM	37045V100	06/20/23	676,420	7.  Proposal Regarding Sustainable Materials Procurement Targets	Non-Routine	Shareholder	06/15/23	AGAINST	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	1.  Election of Directors - 10 Nominees	Routine	Management	06/15/23	FOR	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	2.  Approval of the Advisory Resolution on Executive Compensation	Routine	Management	06/15/23	FOR	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	3.  Advisory Vote with Respect to the Frequency of Future Advisory Votes on Executive Compensation	Routine	Management	06/15/23	1 YEAR	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	4.  Approval of the Amendment to the Company's Certificate of Incorporation	Non-Routine	Management	06/15/23	FOR	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	5.  Approval of the Amendments to the Company's Stock Incentive Plan	Non-Routine	Management	06/15/23	FOR	WITH
PVH Corp.	PVH	693656100	06/22/23	346,730	6.  Ratify the Appointment of Ernst & Young LLP as the Company's Independent Auditors	Routine	Management	06/15/23	FOR	WITH

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Sound Shore Fund, Inc.

By:	/s/ T. Gibbs Kane, Jr.
	T. Gibbs Kane, Jr.
	President
Date:	August 17, 2023